Type 1 tyrosinemia in Finland: a nationwide study

被引:0
|
作者
Linnea Äärelä
Pauliina Hiltunen
Tea Soini
Nina Vuorela
Heini Huhtala
Pasi I. Nevalainen
Markku Heikinheimo
Laura Kivelä
Kalle Kurppa
机构
[1] Tampere University,Center for Child Health Research
[2] Tampere University Hospital,Department of Pediatrics
[3] University of Helsinki and Helsinki University Hospital,Children’s Hospital and Pediatric Research Center
[4] Tampere University,Faculty of Social Sciences
[5] Tampere University Hospital,Department of Internal Medicine
[6] Seinäjoki Central Hospital and the University Consortium of Seinäjoki,Department of Pediatrics
[7] Tampere Center for Child Health Research,undefined
关键词
Tyrosinemia; Succinylacetone; Liver transplant; Nitisinone; Screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Tyrosinemia type 1 - Molecular characterization of 10 Portuguese patients
    Candeias, C.
    Leao, E.
    Lopes, A.
    Quelhas, D.
    Silva, E.
    Martins, E.
    Diogo, L.
    Marques, J. S.
    Eusebio, F.
    Prata, M. F.
    Vilarinho, L.
    Cardoso, M. L.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 24 - 24
  • [42] CHRONIC FORM OF TYROSINEMIA TYPE 1 PRESENTED WITH RICKETS SIGNS
    Dikme, G.
    Soyucen, E.
    Zorer, G.
    Canpolat, N.
    Aydin, A.
    Tuysuz, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2010, 33 : S28 - S28
  • [43] EFFECTIVENESS OF SPECIFIC NUTRITIONAL SUPPORT IN PATIENTS WITH TYROSINEMIA TYPE 1
    Herrero, M.
    Cortes, P.
    Morais, A.
    Ros, I.
    Galera, R.
    Blanca, J. A.
    Lama, R. A.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 50 : E183 - E183
  • [44] NTBC therapy for tyrosinemia type 1: How much is enough?
    El-Karaksy, H. K.
    Rashed, M. S.
    El-Sayed, R.
    El-Raziky, M. S.
    El-Koofy, N. M.
    El-Hawary, M. A.
    Al-Dirbashi, O.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S332 - S332
  • [45] Heme as an initial treatment for severe decompensation in tyrosinemia type 1
    Neeleman, Rochus A.
    Wilson, J. H. Paul
    Williams, Monique
    Langendonk, Janneke G.
    GENETICS IN MEDICINE, 2020, 22 (02) : 437 - 438
  • [46] Discontinuation of NTBC after liver transplantation in tyrosinemia type 1
    Kurihara, Kosuke
    Toyoda, Hidemi
    Amoano, Keishirou
    Inoue, Mikihiro
    Uchida, Keiichi
    Sakurai, Hiroyuki
    Hayashi, Akinobu
    Hirayama, Masahiro
    PEDIATRICS INTERNATIONAL, 2018, 60 (11) : 1039 - 1041
  • [47] Implementation of a Methodology for the Detection of Biochemical Markers in Type 1 Tyrosinemia
    Fuentes Cortes, Iovana
    Pacheco Suarez, Beliany
    Charon Savon, Dulce Maria
    FINLAY, 2023, 13 (04): : 425 - 434
  • [48] Severe neurological crisis in adult patients with Tyrosinemia type 1
    Dawson, Charlotte
    Ramachandran, Radha
    Safdar, Samreen
    Murphy, Elaine
    Swayne, Orlando
    Katz, Jonathan
    Newsome, Philip N.
    Geberhiwot, Tarekegn
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1732 - 1737
  • [49] Optimizing Therapeutic Base Editing for Hereditary Tyrosinemia Type 1
    Dumitru, Ana Maria
    Berkowitz, Cara
    Whittaker, Madelynn
    Wang, Xiao
    Kus, Nicole
    Luks, Valerie
    Riley, John
    Carpenter, Marco
    Archer, Nicholas F.
    Brooks, Dominique
    Johnston, William
    Alameh, Mohamad Gabriel
    Musunuru, Kiran
    Peranteau, William
    MOLECULAR THERAPY, 2023, 31 (04) : 83 - 84
  • [50] A NEW MEDICAL-TREATMENT OF TYROSINEMIA TYPE-1
    DREYFUS, JC
    M S-MEDECINE SCIENCES, 1992, 8 (10): : 1111 - 1112